From: An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype
Comparison name | Combined | OA+NL | OA or NL | |||
---|---|---|---|---|---|---|
Comparison description | RA vs (OA or NL) or (OA+NL) | RA vs OA+NL | RA vs OA or NL | |||
Pathway name | EF ( q -value) | # of DMGs (%) | EF ( q -value) | # of DMGs (%) | EF ( q -value) | # of DMGs (%) |
Rheumatoid arthritis | 2.5 (0.00266) | 24 (27.0) | 6.5 (1.91e-05) | 12 (13.5) | 2.3 (0.00467) | 22 (24.7) |
NOD-like receptor signaling pathway | 2.5 (0.00741) | 16 (27.6) | 5.8 (0.0014) | 7 (12.1) | 2.3 (0.0374) | 14 (24.1) |
Cell adhesion molecules (CAMs) | 1.8 (0.0294) | 25 (19.4) | 3.0 (0.0232) | 8 (6.2) | 1.8 (0.0343) | 25 (19.4) |
Focal adhesion | 1.6 (0.0287) | 35 (17.6) | Â | Â | 1.6 (0.0321) | 35 (17.6) |
Cytosolic DNA-sensing pathway | Â | Â | 4.6 (0.0202) | 5 (9.6) | Â | Â |
Cytokine-cytokine receptor interaction | Â | Â | 2.3 (0.0231) | 12 (4.8) | Â | Â |
Toll-like receptor signaling pathway | 1.9 (0.0377) | 19 (20.7) | Â | Â | Â | Â |
Complement and coagulation cascades | 2.0 (0.0494) | 15 (21.7) | Â | Â | Â | Â |
Staphylococcus aureus infection | 2.9 (0.00379) | 16 (31.4) | 4.7 (0.019) | 5 (9.8) | 2.9 (0.00457) | 16 (31.4) |
Graft-versus-host disease | 2.7 (0.0211) | 11 (29.7) | 10.4 (2.66e-05) | 8 (21.6) | 2.5 (0.0468) | 10 (27.0) |
Allograft rejection | 2.6 (0.031) | 10 (28.6) | 9.6 (0.000159) | 7 (20.0) | 2.7 (0.0389) | 10 (28.6) |
Leishmaniasis | 2.0 (0.0451) | 15 (22.1) | 4.9 (0.00304) | 7 (10.3) | 2.1 (0.048) | 15 (22.1) |
Toxoplasmosis | 1.7 (0.0435) | 24 (18.8) | 3.4 (0.00759) | 9 (7.0) | 1.7 (0.046) | 24 (18.8) |
Viral myocarditis | 2.6 (0.00392) | 19 (27.9) | Â | Â | 2.6 (0.00457) | 19 (27.9) |
Dilated cardiomyopathy | 2.3 (0.00489) | 22 (24.7) | Â | Â | 2.3 (0.00467) | 22 (24.7) |
Hypertrophic cardiomyopathy (HCM) | 2.3 (0.00487) | 21 (25.3) | Â | Â | 2.2 (0.00904) | 20 (24.1) |
Aldosterone-regulated sodium reabsorption | 2.8 (0.00761) | 13 (31.0) | Â | Â | 2.9 (0.00814) | 13 (31.0) |
Influenza A | 1.7 (0.0308) | 29 (18.4) | 4.0 (0.000283) | 13 (8.2) | Â | Â |
Type II diabetes mellitus | 2.5 (0.0185) | 13 (27.7) | Â | Â | 2.6 (0.0203) | 13 (27.7) |
Carbohydrate digestion and absorption | 2.6 (0.0225) | 12 (27.9) | Â | Â | 2.4 (0.0474) | 11 (25.6) |
Type I diabetes mellitus | Â | Â | 8.2 (0.000269) | 7 (17.1) | Â | Â |
Asthma | Â | Â | 10.3 (0.000274) | 6 (21.4) | Â | Â |
Tuberculosis | Â | Â | 3.8 (0.000386) | 13 (7.9) | Â | Â |
Antigen processing and presentation | Â | Â | 5.7 (0.000668) | 8 (11.9) | Â | Â |
Phagosome | Â | Â | 3.7 (0.00131) | 11 (7.7) | Â | Â |
Autoimmune thyroid disease | Â | Â | 6.9 (0.00152) | 6 (14.3) | Â | Â |
Intestinal immune network for IgA production | Â | Â | 6.3 (0.00233) | 6 (13.0) | Â | Â |
Chagas disease (American trypanosomiasis) | 2.0 (0.0206) | 22 (21.4) | Â | Â | Â | Â |
Prion diseases | Â | Â | 5.5 (0.0246) | 4 (11.4) | Â | Â |
African trypanosomiasis | 2.6 (0.031) | 10 (28.6) | Â | Â | Â | Â |